Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.

[1]  K. Baumann,et al.  NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring. , 2009, Bioorganic & medicinal chemistry letters.

[2]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[3]  Wei Zhang,et al.  Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity. , 2009, Bioorganic & medicinal chemistry.

[4]  Birgit Dümpelfeld,et al.  Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase. , 2009, Biochemistry.

[5]  M. Botta,et al.  Synthesis, modeling, and RET protein kinase inhibitory activity of 3- and 4-substituted beta-carbolin-1-ones. , 2008, Journal of medicinal chemistry.

[6]  S. D’Mello,et al.  Synthesis and Structure-Activity Relationship Studies of 3-Substituted Indolin-2-ones as Effective Neuroprotective Agents , 2008, Experimental biology and medicine.

[7]  Alessandra Gianoncelli,et al.  Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening. , 2008, Bioorganic & medicinal chemistry letters.

[8]  E. Mandelkow,et al.  Curcumin‐Derived Pyrazoles and Isoxazoles: Swiss Army Knives or Blunt Tools for Alzheimer's Disease? , 2008, ChemMedChem.

[9]  P. Greengard,et al.  Regulation of Alzheimer's disease amyloid-β formation by casein kinase I , 2007, Proceedings of the National Academy of Sciences.

[10]  C. Haass,et al.  Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators. , 2006, Journal of medicinal chemistry.

[11]  P. Renard,et al.  Studies towards the conception of new selective PPARβ/δ ligands , 2006 .

[12]  Ping-Chiang Lyu,et al.  Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies. , 2006, Journal of medicinal chemistry.

[13]  E. Ongini,et al.  Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action , 2004, Journal of neurochemistry.

[14]  Rong Wang,et al.  Purification and characterization of the human gamma-secretase complex. , 2004, Biochemistry.

[15]  S. Weggen,et al.  Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity* , 2003, Journal of Biological Chemistry.

[16]  C. Dvorak,et al.  A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines. , 2003, Journal of medicinal chemistry.

[17]  T. Iwatsubo,et al.  Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation* , 2003, The Journal of Biological Chemistry.

[18]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[19]  D. Beher,et al.  Generation of C‐terminally truncated amyloid‐β peptides is dependent on γ‐secretase activity , 2002 .

[20]  Rong Wang,et al.  A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.

[21]  Graeme Irvine Stevenson,et al.  L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .

[22]  Martin Egli,et al.  Crystal Structure of a Conformation-selective Casein Kinase-1 Inhibitor* , 2000, The Journal of Biological Chemistry.

[23]  Min Xu,et al.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Ozga,et al.  Effect of halogen substitution of indole-3-acetic acid on biological activity in pea fruit , 1995 .

[25]  C. Haass,et al.  N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated γ-secretase , 2007 .